These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35802403)

  • 21. Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study.
    Lam CK; McGinnis Pilote K; Haque A; Burzynski J; Chuck C; Macaraig M
    J Med Internet Res; 2018 Nov; 20(11):e287. PubMed ID: 30459146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asynchronous Video Directly Observed Therapy to Monitor Short-Course Latent Tuberculosis Infection Treatment: Results of a Randomized Controlled Trial.
    Garfein RS; Liu L; Cepeda J; Graves S; San Miguel S; Antonio A; Cuevas-Mota J; Mercer V; Miller M; Catanzaro DG; Rios P; Raab F; Benson CA
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae180. PubMed ID: 38665171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.
    Story A; Garfein RS; Hayward A; Rusovich V; Dadu A; Soltan V; Oprunenco A; Collins K; Sarin R; Quraishi S; Sharma M; Migliori GB; Varadarajan M; Falzon D
    Emerg Infect Dis; 2016 Mar; 22(3):538-40. PubMed ID: 26891363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial.
    Huang R; Ren G; Hu J
    Trials; 2017 Jul; 18(1):286. PubMed ID: 28673323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Carvalho AC; Moreira J; Cubelo P; Cantista P; Branco CA; Guimarães B
    Trials; 2021 Apr; 22(1):268. PubMed ID: 33845878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial.
    Tanigawa T; Nomura A; Kuroda M; Muto T; Hida E; Satake K
    JMIR Res Protoc; 2019 Jul; 8(7):e12701. PubMed ID: 31290402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COMPARISON OF GeneXpert MTB/RIF ASSAY WITH CONVENTIONAL AFB SMEAR FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN NORTHEASTERN THAILAND.
    Reechaipichitkul W; Suleesathira T; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2017 Mar; 48(2):313-21. PubMed ID: 29641882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country.
    Fekadu G; Jiang X; Yao J; You JHS
    Int J Infect Dis; 2021 Dec; 113():271-278. PubMed ID: 34688946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Smoking Cessation Smartphone App Integrated With a Mobile Carbon Monoxide Checker for Smoking Cessation Treatment: Protocol for a Randomized Controlled Trial.
    Nomura A; Tateno H; Masaki K; Muto T; Suzuki S; Satake K; Hida E; Fukunaga K
    JMIR Res Protoc; 2019 Feb; 8(2):e12252. PubMed ID: 30741641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
    Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA
    PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Adaptive Feedback in a Smartphone-Based Serious Game on Health Care Providers' Knowledge Gain in Neonatal Emergency Care: Protocol for a Randomized Controlled Trial.
    Tuti T; Winters N; Muinga N; Wanyama C; English M; Paton C
    JMIR Res Protoc; 2019 Jul; 8(7):e13034. PubMed ID: 31350837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial.
    Lewis JJ; Liu X; Zhang Z; Thomas BV; Vassall A; Sweeney S; Caihong X; Dongmei H; Xue L; Yongxin G; Huan S; Shiwen J; Fielding KL
    Trials; 2018 Jul; 19(1):398. PubMed ID: 30045757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial.
    Burzynski J; Mangan JM; Lam CK; Macaraig M; Salerno MM; deCastro BR; Goswami ND; Lin CY; Schluger NW; Vernon A;
    JAMA Netw Open; 2022 Jan; 5(1):e2144210. PubMed ID: 35050357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and acceptability of asynchronous VOT among patients with MDR-TB.
    Casalme DJO; Marcelo DB; Dela Cuesta DM; Tonquin M; Frias MVG; Gler MT
    Int J Tuberc Lung Dis; 2022 Aug; 26(8):760-765. PubMed ID: 35898139
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.